DS-1040 (Tosylate) prodrug-1
DS-1040 Tosylate prodrug-1 (Compound 2) is a prodrug of DS-1040 Tosylate (Compound 1). DS-1040 Tosylate prodrug-1 can be used to study thromboembolic diseases[1].
Product Specifications
CAS Number
1335138-79-8
UNSPSC
12352005
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Cardiovascular Disease
Smiles
O=C(O)[C@H](CC1=CN([C@H]2CC[C@H](C)CC2)C=N1)CCCNC(O[C@@H](OC(C(C)C)=O)C)=O
Molecular Formula
C23H37N3O6
Molecular Weight
451.56
References & Citations
[1]Ueda T, et al. Stereoselective Synthesis of TAFIa Inhibitors: Strategic Application of Asymmetric Hydrogenation for the API and Crystallization-Induced Asymmetric Transformation for Its Prodrug. Organic Process Research & Development. 2025 Nov 13.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470177-500 1x 500 µL
CD50 (ICAM-3) (101-1D2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040676-100 1x 100 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941820-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040034-100 1x 100 µL
Cytokeratin 8/18 (C-51), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401003-500 1x 500 µL
Mucin 5AC (MUC5AC) (58M1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details